CompoAtlas

Joint Care Complex

Joint Care Complex, licence 80138020: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Bioventek inc.
NPN or DIN-HM
80138020
Status
Active licence
Licence date
23 January 2025
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Acide hyaluronique

Source : Gallus gallus - Crête

100.0 mgNot calculated
Acide hyaluronique

Source : Hyaluronate de sodium

100.0 mgNot calculated
Collagène hydrolysé

Source : Poissons - Os

150.0 mgNot calculated
Calcium

Source : Calcium L-Threonate

40.0 mg40,000 µg
Magnésium

Source : Produit de chélation de magnésium et de protéine végétale hydrolysée (PVH)

25.0 mg25,000 µg
Sulfate de 2-amino-2-désoxy-D-glucose

Source : Glucosamine Sulfate sodium Chloride

40.0 mgNot calculated
Écorce de Saule

Source : Salix alba - écorce

Extract : Matériel brut sec

Extraction ratio : 5.000:1

Dry plant equivalent : 200 mg

40.0 mgNot calculated

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18.0 ans1.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps in the development and maintenance of bones. Helps support joint health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80138020

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line